Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $3.59 Million - $4.11 Million
-18,050 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $207,700 - $254,877
1,050 Added 6.18%
18,050 $4.26 Million
Q3 2019

Oct 15, 2019

BUY
$174.11 - $208.62 $2.96 Million - $3.55 Million
17,000 New
17,000 $3.29 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Winmill & Co. Inc Portfolio

Follow Winmill & Co. Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winmill & Co. Inc, based on Form 13F filings with the SEC.

News

Stay updated on Winmill & Co. Inc with notifications on news.